
Please try another search
By Senad Karaahmetovic
Shares of Walgreens Boots Alliance (NASDAQ:WBA) are moving lower in pre-open Thursday despite the retail pharmacy chain reporting higher-than-expected FQ1 sales.
Walgreens Boots reported first-quarter EPS of $1.16 to beat the analyst estimate of $1.12. Revenue for the quarter came in at $33.4 billion versus the consensus estimate of $32.83B. The adjusted gross margin came in at 21%, below the 21.3% estimate.
Comparable pharmacy sales rose 4.8% in the quarter compared to the year-ago quarter.
WBA reiterated its FY forecast for adjusted EPS between $4.45 and $4.65 on revenue of $133.5B - $137.5B. Analysts were looking for an adjusted EPS of $4.48 on sales of $134.8B.
Evercore ISI analysts commented:
"Given that it’s FY1Q (+ COVID vagaries), management prudently kept the full year EPS guide. We look forward to updates on the core profit trajectory throughout the rest of the year as well as the results of the transformational cost management plan."
As of 08:34 ET (13:34 GMT), WBA stock is down 4.5%.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.